This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Guangzhou Jet Bio-Filtration Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024. CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Guangzhou Jet Bio-Filtration Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares. CI
Guangzhou Jet Bio-Filtration Co., Ltd. authorizes a Buyback Plan CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guangzhou Jet Bio-Filtration to Buy 0.38% Stake in 3Peak for 75 Million Yuan MT
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Guangzhou Jet Bio-Filtration Co., Ltd.(XSSC:688026) dropped from S&P Global BMI Index CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Guangzhou Jet Bio-Filtration Sees Up to 31% Drop in 2022 Profit MT
Zhuhai Kairui Biotech Co., Ltd. announced that it has received CNY 100 million in funding from Shanghai Yanghe Investment Management Co., Ltd., Guangzhou Jet Bio-Filtration Co., Ltd., Dingsheng Yunchuang Technology, Shenzhen Juke Investment Co., Ltd. CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Guangzhou Jet Bio-Filtration's Shareholders Plan to Unload Stakes CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Bostal Drug Delivery Co., Ltd. announced that it has received $31.4 million in funding from Huatai Zijin Investment Co. Ltd, Guangzhou Chuangyu Investment Management Co., Ltd., Guangzhou Jet Bio-Filtration Co., Ltd., Guangzhou Sanmei Investment Management Center (Limited Partnership) CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
China shares end flat as real estate losses offset auto, tech gains RE
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Jet Bio-Filtration's Shareholder and Party Acting in Concert Plan to Unload Stakes CI
Guangzhou Jet Bio-Filtration Co., Ltd.(XSSC:688026) added to S&P Global BMI Index CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Guangzhou Jet Bio-Filtration Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Chart Guangzhou Jet Bio-Filtration Co., Ltd.
More charts
Guangzhou Jet Biofiltration Co., Ltd. is a China-based company mainly engaged in the research, development, manufacture and sales of biological laboratory consumable products. The Company focuses on disposable plastic consumables for cell culture and related liquid handling biological laboratories. Its main products include biological culture type and liquid handling type, as well as reagents and small laboratory equipment. The Company distributes its products in domestic and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
12.19 CNY
Average target price
14 CNY
Spread / Average Target
+14.85%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688026 Stock
  4. News Guangzhou Jet Bio-Filtration Co., Ltd.
  5. Guangzhou Jet Bio-Filtration Sees Up to 31% Drop in 2022 Profit